Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values
- PMID: 34822110
- DOI: 10.1007/s12031-021-01942-3
Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values
Abstract
The Group 3 Medulloblastoma (Grp3-MB) is an aggressive molecular subtype with a high incidence of metastasis and deaths. In this study, were used an RNA sequencing data (RNA-Seq) from a Brazilian cohort of MBs to identify hub genes associated with the metastatic risk. Data validation were performed by using multiple large datasets from MBs (GSE85217, GSE37418, and EGAS00001001953). DESeq2 package in R software was used to identify the differentially expressed genes (DEGs) in our RNA-Seq data. The DEGs data were accessed to construct the modules/graphs of co-expression and to identify hub genes through Cytoscape platform. The coregulated genes were enriched by the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and the protein-protein interaction (PPI) network was visualized by Cytoscape. The Kaplan-Meier plotter and ROC curves were used to validate the diagnostic and prognostic values of specific biomarkers identified through this model. We identified that inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) as a downregulated hub gene, with a high diagnostic accuracy to Grp3-MBs and associated with tumor metastasis. In addition, we identified genes significantly correlated with ITPR1 that were associated with metastasis in Grp3-MB (ATP1A2, MTTL7A, and RGL1) and worst overall survival in MBs (ANTXR1 and RGL1). Our findings suggest that the ITPR1 hub gene is potentially involved in the metastatic process for Grp3-MB. Our data also provide evidence of targets that may serve as prognostic predictors and/or regulators for the metastatic process that maybe explored for further research of individualized therapy to Grp3-MBs.
Keywords: Bioinformatic analysis; Grp3-MB; ITPR1, Metastasis; RNA-Seq.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.Cell Transplant. 2019 Dec;28(1_suppl):76S-86S. doi: 10.1177/0963689719893950. Epub 2019 Dec 11. Cell Transplant. 2019. PMID: 31822116 Free PMC article.
-
Identification of potential crucial genes and mechanisms associated with metastasis of medulloblastoma based on gene expression profile.Neurol Res. 2023 Mar;45(3):260-267. doi: 10.1080/01616412.2022.2132457. Epub 2022 Oct 10. Neurol Res. 2023. PMID: 36215435
-
Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.Thorac Cancer. 2020 Apr;11(4):851-866. doi: 10.1111/1759-7714.13298. Epub 2020 Feb 14. Thorac Cancer. 2020. PMID: 32059076 Free PMC article.
-
Identification of Potential Key Genes and Molecular Mechanisms of Medulloblastoma Based on Integrated Bioinformatics Approach.Biomed Res Int. 2022 Jan 4;2022:1776082. doi: 10.1155/2022/1776082. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9853643. doi: 10.1155/2024/9853643. PMID: 35127939 Free PMC article. Retracted.
-
Identification of PBK as a hub gene and potential therapeutic target for medulloblastoma.Oncol Rep. 2022 Jul;48(1):125. doi: 10.3892/or.2022.8336. Epub 2022 May 20. Oncol Rep. 2022. PMID: 35593307 Free PMC article.
Cited by
-
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.Acta Neuropathol. 2022 Aug;144(2):339-352. doi: 10.1007/s00401-022-02460-1. Epub 2022 Jun 30. Acta Neuropathol. 2022. PMID: 35771282 Free PMC article.
-
The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.Cells. 2022 May 14;11(10):1645. doi: 10.3390/cells11101645. Cells. 2022. PMID: 35626682 Free PMC article. Review.
-
[RGL1 overexpression promotes metastasis of colorectal cancer by upregulating motile focal adhesion assembly via activating the CDC42/RAC1 complex].Nan Fang Yi Ke Da Xue Xue Bao. 2025 May 20;45(5):1031-1038. doi: 10.12122/j.issn.1673-4254.2025.05.16. Nan Fang Yi Ke Da Xue Xue Bao. 2025. PMID: 40415435 Free PMC article. Chinese.
-
Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells.Hum Cell. 2023 Nov;36(6):2129-2139. doi: 10.1007/s13577-023-00954-y. Epub 2023 Jul 17. Hum Cell. 2023. PMID: 37460706
-
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.Acta Neuropathol. 2023 Jun;145(6):829-842. doi: 10.1007/s00401-023-02575-z. Epub 2023 Apr 24. Acta Neuropathol. 2023. PMID: 37093271
References
-
- Bogdanov A, Moiseenko FV, Dubina M (2017) Abnormal expression of ATP1A1 and ATP1A2 in breast cancer. F1000Research 6:10. https://doi.org/10.12688/f1000research.10481.1
-
- Bozhilova LV, Whitmore AV, Wray J et al (2019) Measuring rank robustness in scored protein interaction networks. BMC Bioinformatics 20:446. https://doi.org/10.1186/s12859-019-3036-6 - DOI - PubMed - PMC
-
- Castillo‑Rodríguez RA, Dávila‑Borja VM, Juárez‑Méndez S (2018) Data mining of pediatric medulloblastoma microarray expression reveals a novel potential subdivision of the Group 4 molecular subgroup. Oncol Lett. https://doi.org/10.3892/ol.2018.8094 - DOI
-
- Cavalli FMG, Remke M, Rampasek L et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e6. https://doi.org/10.1016/j.ccell.2017.05.005 - DOI - PubMed - PMC
-
- Chen D, Bhat-Nakshatri P, Goswami C et al (2013) ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer. Cancer Res 73:5821–5833. https://doi.org/10.1158/0008-5472.CAN-13-1080 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous